Equity

Key Financial Ratios Home > Equity > Corporate Information > Key Financial Ratios

Kilitch Drugs (India) LtdIndustry : Pharmaceuticals - Indian - Formulations
BSE Code:524500 NSE Symbol: KILITCH P/E (TTM) :23.09
ISIN Demat:INE729D01010 Div & Yield %:0 EPS (TTM) :19.37
Book Value (RS) :157.2797549 Market Cap (Rs Cr.):719.2 Face Value (RS) :10
    Change Company 
YearsMar 2024Mar 2023Mar 2022Mar 2021Mar 2020
Debt-Equity Ratio0.130.110.100.090.07
Long Term Debt-Equity Ratio0.000.000.000.000.00
Current Ratio1.431.171.021.201.55
Fixed Assets3.373.183.302.542.27
Inventory43.6533.4624.4815.3011.82
Debtors2.292.493.273.513.03
Interest Cover Ratio12.5617.9118.418.174.67
PBIDTM (%)20.2318.6314.9211.909.03
PBITM (%)19.2917.4914.0110.277.14
PBDTM (%)18.6917.6514.1610.647.50
CPM (%)14.2914.4810.939.086.68
APATM (%)13.3513.3510.017.464.79
ROCE (%)10.749.897.824.202.67
RONW (%)8.398.416.183.321.92

FOR GRIEVANCE MAIL TO invgrieviss@iseindia.com

BSE EQUITIES : INB011077733 | NSE F&O EQUITIES : INF231077737 | NSE CASH MARKET : INB231077737 | NSE CURRENCY DERIVATIVES : INE231077737 | MCX-SX : INE261077737

ISS Enterprise Limited [Erstwhile: ISE Securities & Services Limited], a wholly owned subsidiary of Inter-connected Stock Exchange of India Ltd. (ISE)

© 2013 ISS Enterprise Limited [Erstwhile: ISE Securities & Services Limited]. All rights reserved.

Designed, developed & powered by C-MOTS Infotech (ISO 9001:2008 certified)